AKT/SGK-sensitive phosphorylation of GSK3 in the regulation of L-selectin and perforin expression as well as activation induced cell death of T-lymphocytes

Biochemical and Biophysical Research Communications

Volumn 425, Issue 1, 2012, Pages 6-12

  Bhavsar, Shefalee K ^a   Merches, Katja ^a   Bobbala, Diwakar ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apoptosis; Autoimmune encephalitis; IL2; Perforin; PI3 Kinase

Indexed keywords

CYTOKINE; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; L SELECTIN; PERFORIN; PROTEIN KINASE B; SERUM AND GLUCOCORTICOID REGULATED KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; GENE KNOCK-IN TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; IMMEDIATE-EARLY PROTEINS; L-SELECTIN; LYMPHOCYTE ACTIVATION; MICE; MICE, MUTANT STRAINS; PERFORIN; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; T-LYMPHOCYTES, CYTOTOXIC;

MUS;

EID: 84865191873     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.030     Document Type: Article

References (42)

1. Badorff C., Ruetten H., Mueller S., Stahmer M., Gehring D., Jung F., Ihling C., Zeiher A.M., Dimmeler S. Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J. Clin. Invest. 2002, 109:373-381.
2. Baudot A.D., Jeandel P.Y., Mouska X., Maurer U., Tartare-Deckert S., Raynaud S.D., Cassuto J.P., Ticchioni M., Deckert M. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression. Oncogene 2009, 28:3261-3273.
3. Beurel E., Yeh W.I., Michalek S.M., Harrington L.E., Jope R.S. Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells. J. Immunol. 2011, 186:1391-1398.
4. Li B., Desai S.A., MacCorkle-Chosnek R.A., Fan L., Spencer D.M. A novel conditional Akt 'survival switch' reversibly protects cells from apoptosis. Gene Ther. 2002, 9:233-244.
5. Ono T., Yanagawa Y., Iwabuchi K., Nonomura K., Onoe K. Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization. Immunology 2007, 122:189-198.
6. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 2001, 359:1-16.
7. Mishima M., Tanaka K., Takeiri A., Harada A., Kubo C., Sone S., Nishimura Y., Tachibana Y., Okazaki M. Two structurally distinct inhibitors of glycogen synthase kinase 3 induced centromere positive micronuclei in human lymphoblastoid TK6 cells. Mutat. Res. 2008, 643:29-35.
8. Young W. Review of lithium effects on brain and blood. Cell Transplant. 2009, 18:951-975.
9. Kaytor M.D., Orr H.T. The GSK3 beta signaling cascade and neurodegenerative disease. Curr. Opin. Neurobiol. 2002, 12:275-278.
10. Koros E., Dorner-Ciossek C. The role of glycogen synthase kinase-3beta in schizophrenia. Drug News Perspect. 2007, 20:437-445.
11. Jope R.S., Yuskaitis C.J., Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 2007, 32:577-595.
12. Ren F., Duan Z., Cheng Q., Shen X., Gao F., Bai L., Liu J., Busuttil R.W., Kupiec-Weglinski J.W., Zhai Y. Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism. Hepatology 2011, 54:687-696.
13. Beurel E. Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases. Front. Mol. Neurosci. 2011, 4:18.
14. Hofmann C., Dunger N., Scholmerich J., Falk W., Obermeier F. Glycogen synthase kinase 3-beta: a master regulator of toll-like receptor-mediated chronic intestinal inflammation. Inflamm. Bowel Dis. 2010, 16:1850-1858.
15. Wang H., Brown J., Garcia C.A., Tang Y., Benakanakere M.R., Greenway T., Alard P., Kinane D.F., Martin M. The role of glycogen synthase kinase 3 in regulating IFN-beta-mediated IL-10 production. J. Immunol. 2011, 186:675-684.
16. Heyd F., Lynch K.W. Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing. Mol. Cell 2010, 40:126-137.
17. Garcia C.A., Benakanakere M.R., Alard P., Kosiewicz M.M., Kinane D.F., Martin M. Antigenic experience dictates functional role of glycogen synthase kinase-3 in human CD4+ T cell responses. J. Immunol. 2008, 181:8363-8371.
18. Hughes K., Ramakrishna S., Benjamin W.B., Woodgett J.R. Identification of multifunctional ATP-citrate lyase kinase as the alpha-isoform of glycogen synthase kinase-3. Biochem. J. 1992, 288(Pt 1):309-314.
19. Welsh G.I., Proud C.G. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem. J. 1993, 294(Pt 3):625-629.
20. Shaw M., Cohen P., Alessi D.R. Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett. 1997, 416:307-311.
21. Sakoda H., Gotoh Y., Katagiri H., Kurokawa M., Ono H., Onishi Y., Anai M., Ogihara T., Fujishiro M., Fukushima Y., Abe M., Shojima N., Kikuchi M., Oka Y., Hirai H., Asano T. Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J. Biol. Chem. 2003, 278:25802-25807.
22. Lang F., Bohmer C., Palmada M., Seebohm G., Strutz-Seebohm N., Vallon V. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol. Rev. 2006, 86:1151-1178.
23. McManus E.J., Sakamoto K., Armit L.J., Ronaldson L., Shpiro N., Marquez R., Alessi D.R. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J. 2005, 24:1571-1583.
24. Boini K.M., Bhandaru M., Mack A., Lang F. Steroid hormone release as well as renal water and electrolyte excretion of mice expressing PKB/SGK-resistant GSK3. Pflugers Arch. 2008, 456:1207-1216.
25. Boini K.M., Amann K., Kempe D., Alessi D.R., Lang F. Proteinuria in mice expressing PKB/SGK-resistant GSK3. Am. J. Physiol. Renal Physiol. 2009, 296:F153-F159.
26. Rotte A., Pasham V., Eichenmuller M., Yang W., Qadri S.M., Bhandaru M., Lang F. Regulation of basal gastric acid secretion by the glycogen synthase kinase GSK3. J. Gastroenterol. 2010, 45:1022-1032.
27. Ackermann T.F., Kempe D.S., Lang F., Lang U.E. Hyperactivity and enhanced curiosity of mice expressing PKB/SGK-resistant glycogen synthase kinase-3 (GSK-3). Cell. Physiol. Biochem. 2010, 25:775-786.
28. De Sarno P., Axtell R.C., Raman C., Roth K.A., Alessi D.R., Jope R.S. Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 2008, 181:338-345.
29. Sinclair L.V., Finlay D., Feijoo C., Cornish G.H., Gray A., Ager A., Okkenhaug K., Hagenbeek T.J., Spits H., Cantrell D.A. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat. Immunol. 2008, 9:513-521.
30. Green D.R., Droin N., Pinkoski M. Activation-induced cell death in T cells. Immunol. Rev. 2003, 193:70-81.
31. Krammer P.H., Arnold R., Lavrik I.N. Life and death in peripheral T cells. Nat. Rev. Immunol. 2007, 7:532-542.
32. Krueger A., Fas S.C., Baumann S., Krammer P.H. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 2003, 193:58-69.
33. Lettau M., Paulsen M., Kabelitz D., Janssen O. FasL expression and reverse signalling. Results Probl. Cell Differ. 2009, 49:49-61.
34. Remy I., Michnick S.W. Regulation of apoptosis by the Ft1 protein, a new modulator of protein kinase B/Akt. Mol. Cell. Biol. 2004, 24:1493-1504.
35. Crabtree G.R., Olson E.N. NFAT signaling: choreographing the social lives of cells. Cell 2002, 109(Suppl):S67-S79.
36. Seminario M.C., Precht P., Bunnell S.C., Warren S.E., Morris C.M., Taub D., Wange R.L. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt. Eur. J. Immunol. 2004, 34:3165-3175.
37. Szeto G.L., Pomerantz J.L., Graham D.R., Clements J.E. Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+ T cells. J. Biol. Chem. 2011, 286:11275-11282.
38. M. Lovatt, M.J. Bijlmakers, Stabilization of beta-catenin downstream of T cell receptor signalling, PLoS One. 5 (2010).
39. Alciato F., Sainaghi P.P., Sola D., Castello L., Avanzi G.C. TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. J. Leukoc. Biol. 2010, 87:869-875.
40. Ohtani M., Nagai S., Kondo S., Mizuno S., Nakamura K., Tanabe M., Takeuchi T., Matsuda S., Koyasu S. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 2008, 112:635-643.
41. Wherry E.J., Teichgraber V., Becker T.C., Masopust D., Kaech S.M., Antia R., von Andrian U.H., Ahmed R. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 2003, 4:225-234.
42. Rovedo M.A., Krett N.L., Rosen S.T. Inhibition of glycogen synthase kinase-3 increases the cytotoxicity of enzastaurin. J. Invest. Dermatol. 2011, 131:1442-1449.